The effect of a jail methadone maintenance therapy (MMT) program on inmate recidivism

Addiction

Volumn 103, Issue 12, 2008, Pages 2017-2023

  McMillan, Garnett P ^a   Lapham, Sandra ^a   Lackey, Michael ^a  

^a PACIFIC INSTITUTE FOR RESEARCH AND EVALUATION   (United States)

Author keywords

Corrections; Drug abuse treatment; Drug treatment in jail; Methadone maintenance therapy; Random effects survival models; Recidivism

Indexed keywords

METHADONE;

ARTICLE; DOSE RESPONSE; DRUG DEPENDENCE; DRUG WITHDRAWAL; FEMALE; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OBSERVATIONAL STUDY; ONSET AGE; PRISON; PRISONER; RACE DIFFERENCE; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; UNITED STATES;

FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; NARCOTICS; PRISONERS; PRISONS; PROGRAM EVALUATION; PROSPECTIVE STUDIES; RECURRENCE;

EID: 55649122602     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2008.02361.x     Document Type: Article

References (21)

1. Mclellan A. T., Lewis C. P., O'Brien P., Kleber H. D. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000 284 : 1689 95.
2. Ling W., Wesson D. R. Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Drug Alcohol Depend 2003 70 : S49 S57.
3. Marsch L. A. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction 1998 93 : 515 32.
4. Yoast R., Williams M. A., Deitchman S. D., Champion H. C. Report of the Council on Scientific Affairs: methadone maintenance and needle-exchange programs to reduce the medical and public health consequences of drug abuse. J Addict Med 2001 20 : 15 40.
5. Peters R. H., May R. Drug treatment services in jails. NIDA Research Monograph no. 118. Rockville, MD: National Institute on Drug Abuse 1992.
6. Fiscella K., Moore A., Engerman J., Meldrum S. Jail management of arrestees/inmates enrolled in community methadone maintenance programs. J Urban Health 2004 81 : 645 54.
7. Tomasoni V., Swanson A. J., Nolan J., Human H. The key extended entry program (KEEP): a methadone treatment program for opiate-dependent inmates. Mt Sinai J Med 2001 68 : 14 20.
8. Ball J. C., Lange W. R., Myers C. P., Friedman S. R. Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav 1988 29 : 214 26.
9. National Institutes of Health (NIH). Effective medical treatment of opiate addiction. NIH Consensus Statement 1997 15 : 4.
10. Tims F. M., Leukefeld C. G. The challenge of drug abuse treatment in prisons and jails. NIDA Research Monograph no. 118. Rockville, MD:National Institute on Drug Abuse 1992.
11. Magura S., Rosenblum A., Herman J. Evaluation of in-jail methadone maintenance: preliminary results. NIDA Research Monograph no. 118. Rockville, MD: National Institute on Drug Abuse 1992. Available at: http://www.nida.nih. gov/pdf/monographs/118.pdf (accessed 6 January 2002).
12. McMillan G. P., Lapham S. C. Staff perspectives on methadone maintenance therapy (MMT) in a large southwestern jail. Addict Res Theory 2005 13 : 53 63.
13. Novick D. M., Pascarelli E. F., Joseph H., Salsitz E. A., Richman B. L., Des Jarlais D. C. et al. Methadone maintenance patients in general medical practice. A preliminary report. JAMA 1988 259 : 3299 302.
14. Rich J. D., McKenzie M., Shield D. C., Wolf F. A., Key R. G., Poshkus M. et al. Linkage with methadone treatment upon release from incarceration: a promising opportunity. J Addict Dis 2005 24 : 49 59.
15. Bellin E., Wesson J., Tomasoni V., Nolan J., Glick A. J., Oquendo S. High dose methadone reduces criminal recidivism in opiate addicts. Addict Res 1999 7 : 19 29.
16. Langan P. A., Levin D. J. Recidivism of Prisoners Released in 1994. Washington, DC : US Department of Justice 2002.
17. Merrill J., Alterman A., Cacciola J., Rutherford M. Prior treatment history and its impact on criminal recidivism. J Subst Abuse 1999 17 : 313 9.
18. Collett D. Modelling Survival Data in Medical Research. London : Chapman and Hall 1994.
19. Metzger D. S., Woody G. E., McLellan A. T., O'Brien C. P., Druley P., Navaline H. et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr 1993 6 : 1049 56.
20. Wexler H. K., Melnick G., Risk Cao Y., Substance P. Abuse treatment outcomes: a replication and challenge. Prison J 2004 84 : 106 20.
21. Pelissier B., Jones N., Cadigan T. Drug treatment aftercare in the criminal justice system: a systematic review. J Subst Abuse Treat 2007 32 : 311 20.